Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide.
Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide.
复制标题
通过靶向独特的无引起的CD1D反应T细胞群体对硫化物的反应性,预防自身免疫性。
DOI:
10.1084/jem.20031389
复制
发表时间:
2004-04-05
影响因子:
15.3
通讯作者:
Kumar, V
中科院分区:
文献类型:
--
作者:
Jahng, A;Maricic, I;Aguilera, C;Cardell, S;Halder, RC;Kumar, V
Class I and class II MHC-restricted T cells specific for proteins present in myelin have been shown to be involved in autoimmunity in the central nervous system (CNS). It is not yet known whether CD1d-restricted T cells reactive to myelin-derived lipids are present in the CNS and might be targeted to influence the course of autoimmune demyelination. Using specific glycolipid-CD1d tetramers and cloned T cells we have characterized a T cell population reactive to a myelin-derived glycolipid, sulfatide, presented by CD1d. This population is distinct from the invariant Vα14+ NK T cells, and a panel of Vα3/Vα8+ CD1d-restricted NK T cell hybridomas is unable to recognize sulfatide in the presence of CD1d+ antigen-presenting cells. Interestingly, during experimental autoimmune encephalomyelitis a model for human multiple sclerosis, sulfatide-reactive T cells but not invariant NK T cells are increased severalfold in CNS tissue. Moreover, treatment of mice with sulfatide prevents antigen-induced experimental autoimmune encephalomyelitis in wild-type but not in CD1d-deficient mice. Disease prevention correlates with the ability of sulfatide to suppress both interferon-γ and interleukin-4 production by pathogenic myelin oligodendrocyte glycoprotein-reactive T cells. Since recognition of sulfatide by CD1d-restricted T cells has now been shown both in mice and humans, study of murine myelin lipid-reactive T cells may form a basis for the development of intervention strategies in human autoimmune demyelinating diseases.
登录
查看更多内容
DOI:
10.1084/jem.192.5.741
发表时间:
2000-09-04
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Matsuda JL;Naidenko OV;Gapin L;Nakayama T;Taniguchi M;Wang CR;Koezuka Y;Kronenberg M
通讯作者:
Kronenberg M
影响因子:
15.3
作者:
Park, SH;Weiss, A;Bendelac, A
通讯作者:
Bendelac, A
DOI:
10.1073/pnas.92.21.9510
发表时间:
1995-10-10
影响因子:
11.1
作者:
KUMAR, V;BHARDWAJ, V;SERCARZ, E
通讯作者:
SERCARZ, E
DOI:
10.1084/jem.182.4.993
发表时间:
1995-10-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Cardell S;Tangri S;Chan S;Kronenberg M;Benoist C;Mathis D
通讯作者:
Mathis D
影响因子:
64.8
作者:
Miyamoto, K;Miyake, S;Yamamura, T
通讯作者:
Yamamura, T